Measuring fidelity to delivery of a new smoking cessation intervention integrated into routine tuberculosis care in Pakistan and Bangladesh: Contextual differences and opportunities
- PMID: 33841063
- PMCID: PMC8029647
- DOI: 10.18332/tid/133054
Measuring fidelity to delivery of a new smoking cessation intervention integrated into routine tuberculosis care in Pakistan and Bangladesh: Contextual differences and opportunities
Abstract
Introduction: Tobacco smoking among tuberculosis (TB) patients leads to poorer treatment outcomes. Smoking cessation support should be integrated into routine TB care. We measured healthcare providers' fidelity to a smoking cessation intervention integrated into routine TB care, in Bangladesh and Pakistan. We aimed to understand the role of providers and settings in the implementation of behavior support (BS) messages for TB and smoking cessation.
Methods: The integrated BS intervention was implemented in TB clinics (24 public and 1 private). Cross-sectional data were collected on the fidelity of delivery of the BS intervention using a predefined fidelity index based on an existing validated method of measuring intervention fidelity. Audio-recordings of patient-provider BS sessions were coded using the fidelity index. Intervention fidelity was presented as the proportion of sessions that implemented BS messages.
Results: A total of 96 sessions were conducted, 37 in Bangladesh and 59 in Pakistan. In public settings, TB medication advice was offered in 91.9% (95% CI: 78.7- 97.2) of sessions in Bangladesh, and in 75.5% (95% CI: 62.4-85.1) of sessions in Pakistan; whilst it was offered in 83.3% (95% CI: 43.7-97.0) of sessions in the private setting in Pakistan. Patients' smoking status was assessed in 70.3% (95% CI: 54.2-82.5) of sessions in Bangladesh, and in 34.0% (95% CI: 22.7-47.4) of sessions in the public setting and in 66.7% (95% CI: 30.0-90.3) of sessions in the private setting in Pakistan. A quit date was set in 32.4% (95% CI: 19.6-48.5) of all sessions in Bangladesh, and in 33.3% (95% CI: 9.6-70.0) of all sessions in the public setting in Pakistan.
Conclusions: Fidelity to the intended delivery of the intervention was found to be high for TB-related messages but not for smoking cessation messages. Clinic contexts may play a mediating role in health workers' opportunities to deliver the intervention as planned.
Trial registration: International Standard Randomized Clinical Trial Number (ISRCTN43811467). Registered 23 March 2016, https://doi.org/10.1186/ISRCTN43811467.
Keywords: South Asia; behavior change; primary health care; tobacco.
© 2021 Boeckmann M. et al.
Conflict of interest statement
The authors have each completed and submitted an ICMJE form for disclosure of potential conflicts of interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. K. Siddiqi reports grants from European Commission H2020, and non-financial support from Aflofarm, during the conduct of the study. D. Kotz reports that he received an unrestricted grant from Pfizer in 2009 for an investigator-initiated trial on the effectiveness of practice nurse counselling and varenicline for smoking cessation in primary care (Dutch Trial Register NTR3067; DOI: 10.1111/add.13927).
Figures
Similar articles
-
Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial.BMJ Open. 2022 Aug 26;12(8):e049644. doi: 10.1136/bmjopen-2021-049644. BMJ Open. 2022. PMID: 36028279 Free PMC article. Clinical Trial.
-
Protocol for the mixed-methods process and context evaluation of the TB & Tobacco randomised controlled trial in Bangladesh and Pakistan: a hybrid effectiveness-implementation study.BMJ Open. 2018 Mar 30;8(3):e019878. doi: 10.1136/bmjopen-2017-019878. BMJ Open. 2018. PMID: 29602847 Free PMC article.
-
mHealth intervention (mTB-Tobacco) for smoking cessation in people with drug-sensitive pulmonary tuberculosis in Bangladesh and Pakistan: protocol for an adaptive design, cluster randomised controlled trial (Quit4TB).BMJ Open. 2025 Feb 25;15(2):e089007. doi: 10.1136/bmjopen-2024-089007. BMJ Open. 2025. PMID: 40000077 Free PMC article.
-
Identifying Active Ingredients, Working Mechanisms, and Fidelity Characteristics Reported in Smoking Cessation Interventions in Dutch Primary Care: A Systematic Review.Nicotine Tob Res. 2022 Mar 26;24(5):654-662. doi: 10.1093/ntr/ntab236. Nicotine Tob Res. 2022. PMID: 34788849 Free PMC article.
-
Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.Health Technol Assess. 2023 Mar;27(4):1-277. doi: 10.3310/KLTG1447. Health Technol Assess. 2023. PMID: 37022933 Free PMC article.
Cited by
-
Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial.BMJ Open. 2022 Aug 26;12(8):e049644. doi: 10.1136/bmjopen-2021-049644. BMJ Open. 2022. PMID: 36028279 Free PMC article. Clinical Trial.
-
A complex ePrescribing-based Anti-Microbial Stewardship (ePAMS+) intervention for hospitals combining technological and behavioural components: protocol for a feasibility trial.Pilot Feasibility Stud. 2023 Jan 28;9(1):18. doi: 10.1186/s40814-022-01230-w. Pilot Feasibility Stud. 2023. PMID: 36709308 Free PMC article.
References
-
- World Health Organization . A WHO/The Union Monograph on TB and Tobacco Control. Geneva: World Health Organization; 2007. https://apps.who.int/iris/bitstream/handle/10665/43812/9789241596220_eng.... Accessed May 30, 2017.
LinkOut - more resources
Full Text Sources
Other Literature Sources